Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jul. 02, 2023
Operating activities:
Net income	$ 81,373	$ 605,034
Loss (income) from discontinued operations, net of income taxes	19,929	(521,567)
Income from continuing operations	101,302	83,467
Adjustments to reconcile net income from continuing operations to net cash provided by continuing operations:
Restructuring and other costs, net	22,201	5,104
Depreciation and amortization	215,146	217,938
Gain (Loss) on Extinguishment of Debt	0	(3,345)
Stock-based compensation	22,218	23,526
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	6,349	1,085
Amortization of deferred debt financing costs and accretion of discounts	3,509	3,818
Change in fair value of financial securities	(6,971)	(745)
Unrealized Foreign Exchange (Gain) Loss Related to Proceed from Sale of Business	(857)	23,679
Changes in operating assets and liabilities which provided (used) cash, excluding effects from companies purchased and divested:
Accounts receivable, net	28,194	(10,216)
Inventories	17,251	(26,775)
Accounts payable	(22,974)	(49,225)
Increase (Decrease) in Accrued Expenses and Other	(52,894)	(240,285)
Net cash provided by operating activities of continuing operations	332,474	28,026
Net cash used in operating activities of discontinued operations	(26,290)	(99,882)
Net cash provided by (used in) operating activities	306,184	(71,856)
Investing activities:
Capital expenditures	(39,875)	(34,895)
Purchases of Investments	(4,337)	(5,000)
Payments to Acquire Marketable Securities	0	831,219
Proceeds from Sale and Maturity of Marketable Securities	0	100,000
Cash paid for acquisitions, net of cash acquired	0	(686)
Net cash used in investing activities of continuing operations	(44,212)	(771,800)
Net cash provided by investing activities of discontinued operations	147,522	2,065,261
Net cash provided by investing activities	103,310	1,293,461
Financing activities:
Repayments of Senior Debt	0	(50,835)
Payments of debt financing and equity issuance costs	0	(15)
Net payments on other credit facilities	(11,200)	7,231
Payment for Contingent Consideration Liability, Financing Activities	(8,749)	(10,117)
Proceeds from issuance of common stock under stock plans	6,032	3,215
Purchases of common stock	(30,309)	(273,299)
Dividends paid	(17,282)	(17,638)
Net cash used in financing activities	(61,508)	(341,458)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(12,931)	(17,571)
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalent	335,055	862,576
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at beginning of period	914,373	470,746
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at end of period	1,249,428	1,333,322
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]
Cash and cash equivalents	1,248,120	1,331,903
Restricted Cash, Current	1,308	1,062
Restricted Cash, Noncurrent	0	357
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	1,249,428	1,333,322
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
Non-cash consideration in sale of business	$ 0	$ 261,317